Yissum Research Development Company, the tech-transfer arm of the Hebrew University of Jerusalem, has licensed a portfolio of stem cell-related technologies to biotech firm TheraCell for use in regenerative medical procedures such as spinal fusion.

The technology was invented by a team led by Dan Gazit, a professor from the faculty of dental medicine at Hebrew University. It includes a biologically compatible, oxygenated gel that improves bone regeneration and fusion of bone grafts by increasing local oxygenation and fusion rates at the surgical site.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.